of NHFA guidelines by the Australian Pathology Lipid Interest Group; compares current PBS criteria for subsidised lipid lowering therapy to the NHFA high risk categories and treatment targets; and provides an algorithm for treatment based on the PBS criteria...
14、型糖尿病中,基础蛋白尿是心脏事件的决定因素事件的决定因素cv endpointheart failure0246hazard ratio5.25albuminuria (g/g)0246.52.02.954.4 5.25albuminuria (g/g).52.02.954.4 hazard ratiode zeeuw et al; circulation 2004(adjusted for all conventional risk factors)2006. american college of physicians. ...
LC: U-Prot >300 mg/L0U-Prot = Urinary protein concentration.1 00 RENAAL2CV EndpointHeart Failure0246Hazard ratio5.25Albuminuria (g/g)0246<.52.02.954.4 5.25Albuminuria (g/g)<.52.02.954.4 Hazard ratioDe Zeeuw et al; Circulation 2004(adjusted for all conventional risk factors)©2006...
Introduction Absolute cardiovascular disease (CVD) risk is the numerical probability of a cardiovascular event occurring within a five-year period. Recognising primary health care nurses (PHCNs) integral role in the general practice team, the Heart Foundation Victoria in partnership with the Australian ...
RENAAL研究,2型糖尿病中,基础蛋白尿是心脏事件的决定因素 CV Endpoint Heart Failure 0 2 4 6 Hazard ratio 5.25 Albuminuria (g/g) 0 2 4 6 .5 2.0 2.95 4.4 3 5.25 Albuminuria (g/g) .5 2.0 2.95 4.4 3 Hazard ratio De Zeeuw et al; Circulation 2004 (adjusted for all conventional risk ...
RENAAL研究,2型糖尿病中,基础蛋白尿是心脏事件的决定因素CVEndpointHeartFailure0246Hazardratio5.25Albuminuria(g/g)0246.52.02.954.435.25Albuminuria(g/g).52.02.954.43HazardratioDeZeeuwetal;Circulation2004(adjustedforallconventionalriskfactors)?2006.AmericanCollegeofPhysicians.AllRightsReserved.实用文档 ...
“This is confirmation of Indians having a very high risk of heart disease, and unless this information is acted upon very vigorously by the medical community and the government this risk of cardiovascular disease will translate into large numbers of stroke, heart attack, and cardiovascular death,...
(CVD) or multiple risk factors for vascular disease but without established CVD.1 Scirica 2011/819/2/4 The proportion of patients with multiple risk factors alone is limited to not exceed 25% of the overall study population to ensure that the study population is at sufficiently high risk to...
Medical Center, are the national co-principal investigators of ALLSTAR. “This trial has the potential to be a real game-changer, by shifting patients from high risk (large scars, with likely progression to HF) to low risk (small scars, preserved ventricular structu...
2014, Journal of the American Heart Association Soluble urokinase plasminogen activator receptor : A risk factor for carotid plaque, stroke, and coronary artery disease 2014, Stroke Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque...